Investor Type | Firm |
Industries | Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • Energy • CleanTech • HealthTech (& Fitness) • Healthcare (& Wellness) • Life Science • Oncology • Consumer |
Investing | United States |
Investment Range | $15,930,000 - $15,930,000 |
Mehta Partners, founded in 1997 and headquartered in New York, New York, is a privately held investment manager focusing on the life science, healthcare, and biotechnology sectors. They are known for providing a range of services including managing hedge funds and offering strategic and institutional advisory services. With over two decades of experience in the Biopharma industry, they bring an integrated perspective and a commitment to their clients that distinguishes them in their field. Through their strategic advisory services, they assist in navigating market dynamics, providing insights grounded in thorough research and analysis. Mehta Partners also offers institutional advisory services, leveraging their deep understanding of healthcare investments to guide institutions in their investment decisions. Their research library contains a wealth of documents related to the BioPharma industry, showcasing their focus on staying ahead of industry trends and sharing knowledge. Mehta Partners positions themselves as forward-thinking, emphasizing the importance of long-term strategies and the role of AI in transforming the Biopharma landscape. They aim to understand every protein 'the AI way,' signaling a commitment to cutting-edge methodologies and a vision for the future of the industry. With an investment minimum and maximum of $15,930,000, they cater to specific segments of the market and focus on quality investments rather than quantity. Their website highlights their team's dedication and encourages potential clients to learn about their services and perspectives on the industry's future.